| Feb 11, 2025 |
Feb 12, 2025 |
Apellis Pharmaceuticals, Inc.
|
Chief Business & Strat Officer |
Sell |
51.3
|
-363
|
-0.43%
|
✗
|
$10.4K |
| Jan 29, 2025 |
Jan 30, 2025 |
Apellis Pharmaceuticals, Inc.
|
Chief Business & Strat Officer |
Sell |
51.3
|
-365
|
-0.43%
|
✗
|
$10.8K |
| Jan 22, 2025 |
Jan 23, 2025 |
Apellis Pharmaceuticals, Inc.
|
Chief Business & Strat Officer |
Sell |
46.3
|
-1,396
|
-1.62%
|
✗
|
$42.5K |
| Jan 17, 2025 |
Jan 21, 2025 |
Apellis Pharmaceuticals, Inc.
|
Chief Business & Strat Officer |
Sell |
91.3
|
+27,273
|
46.39%
|
✗
|
$37K |
| Jan 13, 2025 |
Jan 14, 2025 |
Apellis Pharmaceuticals, Inc.
|
Chief Business & Strat Officer |
Sell |
46.3
|
-1,599
|
-2.65%
|
✗
|
$45.9K |
| Mar 18, 2024 |
Mar 19, 2024 |
Apellis Pharmaceuticals, Inc.
|
Chief Business & Strat Officer |
Sell |
20.0
|
-9,913
|
-15.34%
|
✗
|
$564K |
| Feb 12, 2024 |
Feb 13, 2024 |
Apellis Pharmaceuticals, Inc.
|
Chief Business & Strat Officer |
Sell |
48.8
|
-597
|
-0.92%
|
✗
|
$40.5K |
| Jan 29, 2024 |
Jan 31, 2024 |
Apellis Pharmaceuticals, Inc.
|
Chief Business & Strat Officer |
Sell |
48.8
|
-367
|
-0.56%
|
✗
|
$23.5K |
| Jan 22, 2024 |
Jan 23, 2024 |
Apellis Pharmaceuticals, Inc.
|
Chief Business & Strat Officer |
Sell |
42.5
|
-1,384
|
-2.07%
|
✗
|
$90K |
| Jan 16, 2024 |
Jan 17, 2024 |
Apellis Pharmaceuticals, Inc.
|
Chief Business & Strat Officer |
Sell |
95.0
|
+15,332
|
29.70%
|
✗
|
$109K |
| Oct 23, 2023 |
Oct 24, 2023 |
Apellis Pharmaceuticals, Inc.
|
Chief Business & Strat Officer |
Sell |
52.5
|
-131
|
-0.25%
|
✗
|
$6K |
| Feb 21, 2023 |
Feb 22, 2023 |
Apellis Pharmaceuticals, Inc.
|
Chief Business & Strat Officer |
Sell |
91.3
|
+4,839
|
10.41%
|
✗
|
$25.8K |
| Feb 10, 2023 |
Feb 14, 2023 |
Apellis Pharmaceuticals, Inc.
|
Chief Business & Strat Officer |
Sell |
26.3
|
-670
|
-1.42%
|
✗
|
$34.3K |
| Jan 27, 2023 |
Jan 30, 2023 |
Apellis Pharmaceuticals, Inc.
|
Chief Business & Strat Officer |
Sell |
36.3
|
-367
|
-0.77%
|
✗
|
$19.4K |
| Jan 20, 2023 |
Jan 24, 2023 |
Apellis Pharmaceuticals, Inc.
|
Chief Business & Strat Officer |
Sell |
22.5
|
-1,149
|
-2.36%
|
✗
|
$59.8K |
| Oct 20, 2022 |
Oct 24, 2022 |
Apellis Pharmaceuticals, Inc.
|
President |
Sell |
48.8
|
-196
|
-0.67%
|
✗
|
$11.4K |
| Aug 17, 2022 |
Aug 18, 2022 |
Apellis Pharmaceuticals, Inc.
|
President |
Sell |
22.5
|
-5,000
|
-14.60%
|
✓
|
$347.5K |
| Aug 11, 2022 |
Aug 12, 2022 |
Apellis Pharmaceuticals, Inc.
|
President |
Sell |
22.5
|
-5,000
|
-14.60%
|
✓
|
$335K |
| Aug 8, 2022 |
Aug 9, 2022 |
Apellis Pharmaceuticals, Inc.
|
President |
Sell |
22.5
|
-5,000
|
-14.60%
|
✓
|
$322.5K |
| Aug 4, 2022 |
Aug 8, 2022 |
Apellis Pharmaceuticals, Inc.
|
President |
Sell |
7.5
|
-10,000
|
-25.48%
|
✓
|
$607.5K |
| Jul 27, 2022 |
Jul 28, 2022 |
Apellis Pharmaceuticals, Inc.
|
President |
Sell |
22.5
|
-5,000
|
-14.60%
|
✓
|
$285K |
| Jul 19, 2022 |
Jul 21, 2022 |
Apellis Pharmaceuticals, Inc.
|
President |
Sell |
22.5
|
-5,000
|
-14.60%
|
✓
|
$282.1K |
| Jun 16, 2022 |
Jun 21, 2022 |
Apellis Pharmaceuticals, Inc.
|
President |
Sell |
20.0
|
-10,000
|
-25.48%
|
✗
|
$417.9K |
| Apr 20, 2022 |
Apr 22, 2022 |
Apellis Pharmaceuticals, Inc.
|
President |
Sell |
17.5
|
-7,000
|
-19.73%
|
✓
|
$367.7K |
| Feb 10, 2022 |
Feb 14, 2022 |
Apellis Pharmaceuticals, Inc.
|
President |
Sell |
91.3
|
+4,630
|
19.41%
|
✗
|
$12.8K |
| Jan 28, 2022 |
Feb 1, 2022 |
Apellis Pharmaceuticals, Inc.
|
President |
Sell |
46.3
|
-434
|
-2.07%
|
✗
|
$16.7K |
| Jul 21, 2021 |
Jul 22, 2021 |
Apellis Pharmaceuticals, Inc.
|
President |
Sell |
28.8
|
-1,000
|
-9.53%
|
✓
|
$65K |
| Jul 15, 2021 |
Jul 16, 2021 |
Apellis Pharmaceuticals, Inc.
|
President |
Sell |
28.8
|
-1,000
|
-9.53%
|
✓
|
$62.3K |
| Jun 15, 2021 |
Jun 16, 2021 |
Apellis Pharmaceuticals, Inc.
|
President |
Sell |
20.0
|
-4,000
|
-29.65%
|
✗
|
$259.8K |
| May 18, 2021 |
May 19, 2021 |
Apellis Pharmaceuticals, Inc.
|
President |
Sell |
20.0
|
-2,000
|
-17.41%
|
✓
|
$110K |